Logo
Oladoctor – online healthcare marketplace in Spain

Medicamentos de Menarini International Operations Luxembourg S.A. en Spain

R
RANEXA 375 mg PROLONGED-RELEASE TABLETS
Dosage form:  MODIFIED-RELEASE TABLET, 375 mg
Active substance:  ranolazine
Manufacturer:  Menarini International Operations Luxembourg S.A.
Prescription required
RANEXA 500 mg PROLONGED-RELEASE TABLETS
Dosage form:  MODIFIED-RELEASE TABLET, 500 mg
Active substance:  ranolazine
Manufacturer:  Menarini International Operations Luxembourg S.A.
Prescription required
RANEXA 750 mg PROLONGED-RELEASE TABLETS
Dosage form:  MODIFIED-RELEASE TABLET, 750 mg
Active substance:  ranolazine
Manufacturer:  Menarini International Operations Luxembourg S.A.
Prescription required
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.
Follow us on social media